Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 7, 2025 • 10:00 PM ET

Date/Time Source News Release
08/15/2023 08:00 AM EDT PR Newswire RegeneRx Effects Reverse Stock Split and Terminates SEC Reporting Obligations
08/07/2023 04:06 PM EDT PR Newswire RegeneRx Receives Stockholder Approval for Reverse Stock Split
08/01/2023 12:34 PM EDT PR Newswire RegeneRx To Extend Consent Solicitation Vote
04/13/2023 08:04 AM EDT PR Newswire First Patient Enrolled into U.S. Phase 3 Neurotrophic Keratitis Clinical Trial with RGN-259
04/11/2023 04:59 PM EDT PR Newswire RegeneRx Issues Letter To Stockholders
01/31/2023 08:30 AM EST PR Newswire Thymosin Beta 4 Research Leads Toward Potential Future Anti-aging Therapy
01/03/2023 08:14 AM EST PR Newswire Publication of RGN-259 Phase 3 Clinical Trial Results in Patients with Neurotrophic Keratopathy
10/24/2022 10:55 AM EDT PR Newswire RegeneRx Licensee Submits Special Protocol Assessment to FDA for 4th Phase 3 Clinical Trial for Dry Eye Disease
09/27/2022 12:24 PM EDT PR Newswire RegeneRx Partner Submits Phase 3 Protocol for Neurotrophic Keratopathy (NK)
08/22/2022 08:30 AM EDT PR Newswire RegeneRx Issues 2022 Letter To Stockholders
Page

Additional News

As of June 7, 2025 • 10:00 PM ET

Date/Time Source News Release
07/18/2022 10:16 AM EDT SeekingAlpha RegeneRx partner, a global CRO to conduct two phase 3 trials in degenerative eye disease
07/14/2021 08:19 AM EDT SeekingAlpha RegeneRx JV provides regulatory timeline update for RGN-259 BLA
03/22/2021 02:21 PM EDT SeekingAlpha RegeneRx gives updated timeline on late-stage ARISE-3 trial
03/18/2021 07:47 AM EDT SeekingAlpha RegeneRx posts topline results of ARISE-3 dry eye trial
01/26/2021 03:57 PM EST SeekingAlpha RegeneRx addresses rumors regarding late-stage dry eye trial
10/14/2020 11:09 AM EDT SeekingAlpha RegeneRx expects completion of Phase 3 trial for dry eye syndrome drug in November
10/12/2020 04:26 PM EDT SeekingAlpha RegeneRx expects short-term financing from its major shareholder
08/19/2020 10:39 AM EDT SeekingAlpha RegeneRx slips 12% on extended timeline of dry eye study
09/17/2019 02:08 PM EDT SeekingAlpha RegeneRx Biopharmaceuticals (RGRX) Presents At MicroCap Fall Investor Summit - Slideshow
07/25/2019 10:31 AM EDT SeekingAlpha RegeneRx And RGN-137 In Epidermolysis Bullosa: The Story
Page
  • 1
  • 2

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.